Trevi Therapeutics
TRVI
#6339
Rank
โ‚ฌ0.55 B
Marketcap
5,69ย โ‚ฌ
Share price
1.89%
Change (1 day)
140.40%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -0,30ย โ‚ฌ

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -0,27ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,49ย โ‚ฌ an increase over its 2021 EPS that were of -1,32ย โ‚ฌ.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,30ย โ‚ฌ-39.61%
2022-0,49ย โ‚ฌ-62.67%
2021-1,32ย โ‚ฌ-17.29%
2020-1,60ย โ‚ฌ18.17%
2019-1,35ย โ‚ฌ-46.21%
2018-2,51ย โ‚ฌ